KARD is Kardigan, Inc. Common Stock (Healthcare) — a non-dividend-paying stock. Trading at $21.14. Market cap: $1.94B.
Stock snapshot
| Price | $21.14 |
| Market cap | $1.94B |
| Sector | Healthcare |
| Exchange | XNAS |
| Pays dividend | No |
About KARD
Kardigan Inc is a clinical-stage therapeutics company focused on developing medicines for cardiovascular diseases. Its activities include the research and development of targeted therapies for cardiovascular conditions for which no approved treatments currently exist. The company's clinical-stage programs include Danicamtiv, Ataciguat, and Tonlamarsen, which are being developed for cardiovascular disease indications. The company operates and manages its business as a single operating and reportable segment, focused on the discovery and development of novel therapeutic products to treat cardiovascular disease.
Related non-dividend companies
Other non-dividend stocks investors research alongside KARD. Peer set from Massive news + returns similarity, filtered to names we currently track.
Frequently asked
What is KARD's current stock price?
KARD (Kardigan, Inc. Common Stock) is currently trading at $21.14.
Does KARD pay a dividend?
KARD (Kardigan, Inc. Common Stock) does not currently pay a regular dividend.
Track KARD in DiviDrip
Add KARD to your watchlist on DiviDrip to monitor price, fundamentals, and Capital Quality Rank week-over-week. Built for long-term investors tracking both dividend and non-dividend names.
- Open DiviDrip — search KARD and add it to your watchlist.
- Stock Screener — filter by sector, market cap, and Capital Quality Rank.
- How to use the Screener — sector / quality / market-cap filters explained.
Data refreshed 2026-09-04. Not investment advice. Prices change continuously; always verify the latest numbers in the live app before buying.